Revenue - Schedule of Concentration Risk by Customer (Details) - Revenue Benchmark - Customer Concentration Risk |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
|
| McKesson | ||||
| Disaggregation of Revenue [Line Items] | ||||
| Concentration risk percentage | 40.00% | 37.00% | 37.00% | 40.00% |
| AmerisourceBergen Corporation | ||||
| Disaggregation of Revenue [Line Items] | ||||
| Concentration risk percentage | 39.00% | 35.00% | 40.00% | 36.00% |
| Cardinal Health | ||||
| Disaggregation of Revenue [Line Items] | ||||
| Concentration risk percentage | 21.00% | 28.00% | 23.00% | 24.00% |
| X | ||||||||||
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|